- Home
- WBX vs ENGN Comparison
WBX vs ENGN Comparison
Compare WBX & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- ENGN
- Stock Information
- Founded
- WBX 2015
- ENGN 1999
- Country
- WBX Spain
- ENGN Canada
- Employees
- WBX N/A
- ENGN N/A
- Industry
- WBX Industrial Specialties
- ENGN
- Sector
- WBX Consumer Discretionary
- ENGN
- Exchange
- WBX Nasdaq
- ENGN Nasdaq
- Market Cap
- WBX 293.9M
- ENGN 293.1M
- IPO Year
- WBX N/A
- ENGN N/A
- Fundamental
- Price
- WBX $0.64
- ENGN $8.09
- Analyst Decision
- WBX Buy
- ENGN Strong Buy
- Analyst Count
- WBX 3
- ENGN 8
- Target Price
- WBX $1.42
- ENGN $30.38
- AVG Volume (30 Days)
- WBX 688.3K
- ENGN 167.2K
- Earning Date
- WBX 11-06-2024
- ENGN 01-27-2025
- Dividend Yield
- WBX N/A
- ENGN N/A
- EPS Growth
- WBX N/A
- ENGN N/A
- EPS
- WBX N/A
- ENGN N/A
- Revenue
- WBX $179,622,844.00
- ENGN N/A
- Revenue This Year
- WBX $20.24
- ENGN N/A
- Revenue Next Year
- WBX $16.77
- ENGN N/A
- P/E Ratio
- WBX N/A
- ENGN N/A
- Revenue Growth
- WBX 16.10
- ENGN N/A
- 52 Week Low
- WBX $0.50
- ENGN $4.42
- 52 Week High
- WBX $2.09
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- WBX 38.90
- ENGN 46.82
- Support Level
- WBX $0.55
- ENGN $8.00
- Resistance Level
- WBX $0.66
- ENGN $8.89
- Average True Range (ATR)
- WBX 0.06
- ENGN 0.60
- MACD
- WBX 0.01
- ENGN 0.02
- Stochastic Oscillator
- WBX 58.06
- ENGN 34.35
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.